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subsp. enterica serotype 1,4,[5],12:i:- IN SÃO PAULO STATE, BRAZIL: FREQUENCY AND ANTIBIOTIC
RESISTANCE PATTERNS
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SUMMARY
Salmonella spp. are the etiologic agents of salmonellosis, a worldwide spread zoonoses causing foodborne outbreaks and clinical
diseases. By serological identification, Salmonella enterica subsp. enterica serotype 1,4,[5],12:i:- accounted for 8.8% of human and
1.6% of nonhuman Salmonella strains isolated in São Paulo State, during 1991-2000. A total of 28.6% of them amplified a fragment
corresponding to H:1,2 (flagellar phase two) through PCR analysis and were further assigned as S. Typhimurium. Antimicrobial
resistance was detected in 36.3% of the 369 PCR-negative strains tested, including the multiresistance to ampicillin, chloramphenicol,
sulfonamides, tetracycline, and streptomycin.
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Salmonella spp. strains are the etiologic agents of salmonellosis, a
zoonotic disease worldwide spread, and/or enteric fevers depending on
the serotypes involved. Salmonella serotypes have been traditionally
defined through serological identification of somatic (O) and flagellar
(H) factor antigens present in the bacterial cell. Most Salmonella strains
are motile by peritrichous flagella and an important characteristic of the
genus is the presence of two different flagellin genes on the bacterial
chromosome, fliC and fljB (formerly H1 and H2), which expression is
done by a system called “phase variation”8,14. The great majority of the
2,501 Salmonella serotypes listed in the Kauffmann-White scheme10
expresses alternatively both genes (phase one and phase two), being
then called biphasic. The remaining serotypes displaying only one
flagellar phase are designated monophasic.
Salmonella enterica subsp. enterica serotype 1,4,[5],12:i:- (S. I
1,4,[5],12:i:-) is an atypical and emergent monophasic serotype, which
shares almost all antigenic factors with S. enterica subsp. enterica
serotype Typhimurium (S. Typhimurium) (1,4,[5],12:i:1,2), a worldwide
spread Salmonella serotype. Some studies have been carried out in order
to determine the genetic relationship between these serotypes and to
confirm the hypotheses that S. I 1,4,[5],12:i:- is a monophasic variant of
S. Typhimurium5,7. As far as we know, this unusual serotype has been
described since 1993 in Thailand2, in Spain4, and in the U.S.A.1.
In São Paulo, Brazil, S. I 1,4,[5],12:i:- has been detected in samples
of human and nonhuman origins through the last decades, with an
increasing of up to five times in the 90´s, being particularly associated
with human foodborne outbreaks and septicemia cases11,12,13. Besides
that, S. I 1,4,[5],12:i:- has been found among the top five Salmonella
serotypes isolated from human infections in our area, together with S.
Enteritidis and S. Typhimurium. This study reports the “multiplex PCR”
identification of S. I 1,4,[5],12:i:- and its frequency and antimicrobial
resistance patterns, providing baseline for further characterization.
From January 1991 through December 2000, 389 (8.8%) out of 4,426
Salmonella human strains (including 61.0% from feces and 25.0% from
blood) and 128 (1.6%) out of 7,827 nonhuman ones (mostly from
foodstuffs and animals) were identified as S. I 1,4,[5],12:i:- at the
Enteropathogens Laboratory, Instituto Adolfo Lutz, São Paulo. Those
strains were isolated in different cities of São Paulo State. Isolation and
identification of strains at the genus level were performed as described
by EWING6. Salmonella subspecies determination and serotyping were
carried out according to POPOFF10. Every somatic and flagellar antiserum
used for Salmonella serotyping has been produced and maintained by
this Enteropathogens Laboratory.
Those 517 strains were firstly assigned as S. I 1,4,[5],12:i:- by slide
agglutination method with polyclonal antisera and stored in agar slant at
room temperature. Afterwards, they were submitted to the “multiplex
PCR” method described by ECHEITA & USERA3 in order to detect the
gene encoding for the flagellar phase two in the H1 antigenic complex
(H:1,2, H:1,5, H:1,6, H:1,7). One hundred and forty-eight (28.6%) strains
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amplified the 394 bp-fragment specific for H:1,2 being, therefore,
assigned as S. Typhimurium. These results indicate that the undetected
flagellar phase two during the serologic identification is likely to be due
to the low level of bacterial cells expressing this antigen. Thus, the
“Multiplex PCR” proved to be a useful and complementary tool for the
classical serological identification of S. I 1,4,[5],12:i:- strains.
The 369 (289 human and 80 nonhuman) PCR-negative strains were
analyzed for antimicrobial resistance, determined by the disk diffusion
method according to National Committee for Clinical Laboratory
Standards criteria9, against to the following antimicrobial agents
(CECON): amikacin (30 µg), amoxicillin/clavulanic acid (30 µg),
ampicillin (10 µg), aztreonam (30 µg), cefepime (30 µg), ceftazidime
(30 µg), ceftriaxone (30 µg), cephalothin (30 µg), chloramphenicol (30
µg), ciprofloxacin (5 µg), gentamicin (10 µg), imipenem (10 µg),
kanamycin (30 µg), nalidixic acid (30 µg), netilmicin (30 µg),
nitrofurantoin (300 µg), sulfonamides (300 µg), streptomycin (10 µg),
sulfamethoxazole-trimethoprim (25 µg), and tetracycline (30 µg).
The results showed that all strains were susceptible to aztreonam,
cefepime, ceftazidime, ceftriaxone, ciprofloxacin, and imipenem. Table
1 demonstrates that 8% of human and 5% of nonhuman strains were
susceptible to all antimicrobials tested. A total of 208 (56.3%) strains
(55% human and 62.5% nonhuman) presented intermediate resistance,
mostly to tetracycline (91%) and streptomycin (64%). One hundred and
thirty-four (36.3%) strains (37% human and 31% nonhuman) exhibited
resistance to one up to 13 antimicrobial agents, distributed to 30 resistance
patterns (Table 1). Such resistance was mostly to tetracycline (68%),
Table 1
Antimicrobial susceptibility patterns of the 369 S. I 4,5,12:i:- PCR-negative strains, isolated from human and non human sources during 1991-2000, in São Paulo
State, Brazil
Susceptibility pattern No (%) of strains
Human (n = 289) Nonhuman (n = 80)
Susceptible 23 (8.0) 4 (5.0)
Intermediate resistance 158 (55.0) 50 (62.5)
Resistance profile*
TET 53 (18.5) 11 (13.6)
NIT 13 (4.5) 5 (6.0)
SSS - 1 (1.3)
STR 6 (2.1) -
NAL 1 (0.3) -
CEP, NIT 1 (0.3) -
TET, NIT 3 (1.1) 2 (2.5)
TET, CEP 1 (0.3) -
TET, KAN 3 (1.1) -
SSS, NIT 3 (1.1) 1 (1.3)
NIT, STR 1 (0.3) -
TET, NAL 2 (0.7) -
TET, SSS, NIT 2 (0.7) 1 (1.3)
TET, CHL, CEP 1 (0.3) -
TET, SSS, STR 1 (0.3) -
SSS, SXT, STR 1 (0.3) 1 (1.3)
AMP, SSS, STR 1 (0.3) -
AMP, SSS, SXT, STR 3 (1.1) 1 (1.3)
TET, SSS, SXT, STR 1 (0.3) 1 (1.3)
CHL, SSS, SXT, STR 1 (0.3) -
TET, KAN, SSS, SXT, STR 1 (0.3) -
TET, KAN, AMP, SSS, STR 1 (0.3) -
TET, CHL, AMP, CEP, NIT 1 (0.3) -
AMP, AMC, CEP, SSS, SXT, STR 1 (0.3) -
TET, KAN, AMP, SSS, SXT, STR 1 (0.3) -
TET, CHL, AMP, SSS, SXT, STR 1 (0.3) 1 (1.3)
TET, CHL, AMP, SSS, SXT, STR, NIT, NAL - 1 (1.3)
NET, CHL, GEN, KAN, AMP, CEP, SSS, SXT, AMC, STR 1 (0.3) -
NET, CHL, GEN, KAN, AMP, CEP, SSS, SXT, STR, AMK 1 (0.3) -
NET, TET, CHL, GEN, KAN, AMP, CEP, SSS, SXT, AMC, STR, AMK, NAL 2 (0.7) -
* AMK, amikacin; AMC, amoxicillin/clavulanic acid; AMP, ampicillin; CEP, cephalothin; CHL, chloramphenicol; GEN, gentamicin; KAN, kanamycin; NAL,
nalidixic acid; NET, netilmicin; NIT, nitrofurantoin; SSS, sulfonamides; STR, streptomycin; SXT, sulfamethoxazole-trimethoprim; TET, tetracycline.
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nitrofurantoin (25%), sulfonamides (22.4%), and streptomycin (22%).
Eighty percent of these strains were resistant to one or two agents and
20% displayed multiresistance to three or more antimicrobials. ECHEITA
et al.4 in Spain and AGASAN et al.1 in the U.S.A. found a higher level
of multiresistant (including the ampicillin, chloramphenicol,
sulfonamides, streptomycin, tetracycline pattern) S. I 1,4,[5],12:i:- strains
comparing to our results.
Although no strain was resistant to ciprofloxacin, six strains presented
resistance to nalidixic acid. Approximately 90% of the human strains
isolated from blood displayed some resistance or decreased susceptibility
to the antimicrobials suggesting a special concern with such strains.
Multiresistance was found in the same level (5%) for both human and
nonhuman strains. No increase in antibiotic resistance was observed
throughout the period under study.
 Further studies on phenotypic and molecular characterization of S.
I 1,4,[5],12:i:- and S. Typhimurium strains are in progress in this
laboratory by some of us. Data obtained from those studies will be
compared in order to confirm the genetic relationship between these
two serotypes.
RESUMO
Identificação por “Multiplex PCR” do sorotipo monofásico e
atípico Salmonella enterica subsp. enterica sorotipo 1,4,[5],12:i:-,
no Estado de São Paulo, Brasil: freqüência e resistência
antimicrobiana
Salmonella spp. é o agente etiológico da salmonelose, zoonose
mundialmente distribuída e responsável por surtos de doenças
transmitidas por alimentos e doenças clínicas. Sorologicamente,
Salmonella enterica subsp. enterica sorotipo 1,4,[5],12:i:- correspondeu
a 8,8% e 1,6% das cepas de Salmonella de origem humana e não-humana,
respectivamente, isoladas no Estado de São Paulo, no decênio 1991-
2000. Aproximadamente 28,6% destas cepas amplificaram o fragmento
correspondente a H:1,2 (fase flagelar dois) em testes de PCR e foram,
então, identificadas como S. Typhimurium. Das 369 cepas negativas em
PCR, 36,3% apresentou resistência antimicrobiana, incluindo
multirresistência a ampicilina, cloranfenicol, sulfonamidas, tetraciclina
e estreptomicina.
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